Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Nevejan

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Chemistry and Laboratory Medicine|December 2, 2025
Extended verification of an automated MALDI-TOF mass spectrometry system for high throughput serum M-protein measurementLouis Nevejan, Jan Van Droogenbroeck, Emile Van Hecke, et al.
Frontiers in Immunology|December 26, 2025
Beyond the cut-off: harmonizing kappa free light chain index using likelihood ratios improves the clinical interpretation in the diagnosis of multiple sclerosisMatthijs Oyaert, Louis Nevejan, Cathérine Dekeyser, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 17, 2021
Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample typesLouis Nevejan, Thomas Strypens, Mathias Van Nieuwenhove, et al.
Clinical Chemistry and Laboratory Medicine|July 5, 2022
Serum free light chain analysis: persisting limitations with new kids on the blockLieve Van Hoovels, Martine Vercammen, Louis Nevejan, et al.
Journal of Immunological Methods|March 28, 2021
Diagnostic and analytical performance evaluation of ten commercial assays for detecting SARS-CoV-2 humoral immune responseMarnix Mylemans, Eveline Van Honacker, Louis Nevejan, et al.
Clinical Chemistry and Laboratory Medicine|December 6, 2022
Serial measurement of circulating calprotectin as a prognostic biomarker in COVID-19 patients in intensive care settingLouis Nevejan, Thomas Strypens, Mathias Van Nieuwenhove, et al.
Emerging Infectious Diseases|June 23, 2022
Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting PoliciesLouis Nevejan, Lize Cuypers, Lies Laenen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 10, 2021
Circulating calprotectin as biomarker in neutrophil-related inflammation: Pre-analytical recommendations and reference values according to sample typeMarnix Mylemans, Louis Nevejan, Stefanie Van Den Bremt, et al.
Clinical Chemistry and Laboratory Medicine|October 29, 2021
Pre-analytical recommendations and reference values for circulating calprotectin are sample type and assay dependentLouis Nevejan, Marnix Mylemans, Bert Vander Cruyssen, et al.
Viruses|June 24, 2022
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021-2022Nina Van Goethem, Pui Yan Jenny Chung, Marjan Meurisse, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Chemistry and Laboratory Medicine|December 2, 2025
Extended verification of an automated MALDI-TOF mass spectrometry system for high throughput serum M-protein measurementLouis Nevejan, Jan Van Droogenbroeck, Emile Van Hecke, et al.
Frontiers in Immunology|December 26, 2025
Beyond the cut-off: harmonizing kappa free light chain index using likelihood ratios improves the clinical interpretation in the diagnosis of multiple sclerosisMatthijs Oyaert, Louis Nevejan, Cathérine Dekeyser, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 17, 2021
Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample typesLouis Nevejan, Thomas Strypens, Mathias Van Nieuwenhove, et al.
Clinical Chemistry and Laboratory Medicine|July 5, 2022
Serum free light chain analysis: persisting limitations with new kids on the blockLieve Van Hoovels, Martine Vercammen, Louis Nevejan, et al.
Journal of Immunological Methods|March 28, 2021
Diagnostic and analytical performance evaluation of ten commercial assays for detecting SARS-CoV-2 humoral immune responseMarnix Mylemans, Eveline Van Honacker, Louis Nevejan, et al.
Clinical Chemistry and Laboratory Medicine|December 6, 2022
Serial measurement of circulating calprotectin as a prognostic biomarker in COVID-19 patients in intensive care settingLouis Nevejan, Thomas Strypens, Mathias Van Nieuwenhove, et al.
Emerging Infectious Diseases|June 23, 2022
Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting PoliciesLouis Nevejan, Lize Cuypers, Lies Laenen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 10, 2021
Circulating calprotectin as biomarker in neutrophil-related inflammation: Pre-analytical recommendations and reference values according to sample typeMarnix Mylemans, Louis Nevejan, Stefanie Van Den Bremt, et al.
Clinical Chemistry and Laboratory Medicine|October 29, 2021
Pre-analytical recommendations and reference values for circulating calprotectin are sample type and assay dependentLouis Nevejan, Marnix Mylemans, Bert Vander Cruyssen, et al.
Viruses|June 24, 2022
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021-2022Nina Van Goethem, Pui Yan Jenny Chung, Marjan Meurisse, et al.
Pageof 3